Trends in medications for opioid use disorder before surgery by payer type, 2016–2021
Medications for opioid use disorder (MOUD), including buprenorphine, methadone, and extended-release naltrexone, effectively reduce relapse and overdose. Despite recent advances with opioid stewardship, their management in the perioperative setting remains inconsistent. Insurance coverage, including
Authors
- Pooja Lagisetty (ORCID: https://orcid.org/0000-0002-1460-8004)
- Thuy Dieu Nguyen (ORCID: https://orcid.org/0000-0003-3790-6925)
- 戚晓园
- Mark C. Bicket (ORCID: https://orcid.org/0000-0001-9406-5953)
- Kao‐Ping Chua (ORCID: https://orcid.org/0000-0002-4081-272X)
- Chad M. Brummett (ORCID: https://orcid.org/0000-0003-0974-7242)
- Jennifer F. Waljee (ORCID: https://orcid.org/0000-0001-9878-5704)
- Vidhya Gunaseelan
- Yi Li
Institutions
- University of Michigan (US)
- Michigan Medicine (US)
Publication Details
- Journal
- Regional Anesthesia & Pain Medicine
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1136/rapm-2026-108364
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00